U.S. Medical Imaging Market Size, Share & Forecast 2026–2032

ID: MR-11927 | Published: November 2026
Download PDF Sample

Report Highlights

  • ✓Country: United States
  • ✓Market: Medical Imaging
  • ✓Market Size 2024: USD 29.4 billion
  • ✓Market Size 2032: USD 44.8 billion
  • ✓CAGR: 5.4%
  • ✓Base Year: 2025
  • ✓Forecast Period: 2026–2032
Market Growth Chart
Want Detailed Insights - Download Sample
Analyst Findings and Recommendations
FINDING 01
Helium and Isotope Chokepoints: U.S. MRI fleets now buy helium from private suppliers after the Bureau of Land Management sold the federal reserve in 2024. Molybdenum-99 for nuclear imaging still arrives mainly from reactors in the Netherlands and South Africa, creating single-outage exposure.
FINDING 02
Hospitals Lose Capital Control: Contrary to the view that hospital budgets drive U.S. imaging, RadNet and Radiology Partners increasingly control new CT and MRI purchasing. Tariff uncertainty will push that buying toward refurbished systems.
ANALYST RECOMMENDATION

Analyst Recommendation — Lock Supply Contracts Now: Procurement directors at U.S. hospital systems should lock in multi-year helium and component supply contracts before the Section 232 medical device tariff decision, due by mid-2026, to protect service uptime and budgets.

The U.S. in the Global Imaging Supply Chain

The United States is the world's largest medical imaging market and a net importer of finished systems, yet it remains a major producer of high-value platforms. GE HealthCare builds CT and MR systems in Waukesha, Wisconsin, while Siemens Healthineers and Philips maintain domestic assembly, service, and parts hubs. Finished X-ray and ultrasound equipment arrives mainly from Germany, the Netherlands, and Japan, while Mexico supplies cable harnesses and detector modules duty-advantaged under USMCA.

Export strength lies in high-field MRI, PET-CT, and molecular imaging agents. Shipments of imaging equipment flow principally to Canada, Japan, the Netherlands, and Germany, while radiopharmaceuticals from Lantheus in North Billerica, Massachusetts, supply clinics across Europe and Asia. The critical vulnerability sits upstream: X-ray tubes and detectors from Varex Imaging depend on production in Salt Lake City and China, and helium and molybdenum-99 remain concentrated among few foreign suppliers.

Growth Drivers for U.S. Imaging Trade and Production

Three forces are reshaping U.S. imaging production. First, demand for CT and MRI scanning is rising with an ageing Medicare population, and hospitals are replacing aging fleets with domestically serviced systems to limit exposure to foreign parts. Second, GE HealthCare and Siemens Healthineers are expanding U.S. output of detector and magnet components to shorten lead times and satisfy federal procurement preferences. Together these shifts raise domestic value added per unit.

Third, portable and point-of-care systems are creating export-ready niches. Butterfly Network in Burlington, Massachusetts, sells handheld ultrasound probes built on semiconductor chips sourced from Asian foundries, and Hyperfine's low-field portable MRI, assembled in Guilford, Connecticut, is gaining traction in emergency departments abroad. Import substitution is most visible in ultrasound transducers, where domestic makers are qualifying second-source chip suppliers to reduce dependence on single foundries.

Supply Chain Risks and Trade Barriers

Raw material dependency is the most acute risk. Helium for superconducting MRI magnets is priced in a market where federal reserve supply has shrunk, exposing hospitals to spot price spikes. Molybdenum-99, which generates the technetium used in tens of thousands of U.S. nuclear medicine procedures each day, depends on reactors in the Netherlands, Belgium, and South Africa, so a single outage halts scheduling for days.

Trade barriers compound these risks. Section 301 tariffs on Chinese-origin components and the Commerce Department's 2025 Section 232 investigation into medical devices raise landed costs for X-ray tube and detector imports. Yen weakness has made Japanese systems cheaper in dollars, yet euro strength has lifted German equipment prices, leaving hospital capital budgets exposed to currency swings.

Trade and Investment Opportunities in the U.S. Imaging Sector

New export opportunities lie in refurbished and service-led models sold into Latin America and the Middle East. U.S. OEMs that certify refurbished CT and MRI systems can undercut new-unit pricing while retaining control of spare parts flows. Contract manufacturers in Tijuana and Ciudad Juárez offer a nearshoring hub for detector modules, cables, and mechanical assemblies that feed U.S. final assembly under USMCA rules of origin.

Inbound investment should target isotope and component capacity. Backing domestic molybdenum-99 production, such as NorthStar Medical Radioisotopes in Beloit, Wisconsin, addresses a structural gap in supply. Logistics hubs around Memphis and Louisville can serve as distribution points for time-sensitive radiopharmaceuticals, shortening transit to hospitals across the Southeast.

Market at a Glance

MetricValue
Market Size 2024USD 29.4 billion
Market Size 2032USD 44.8 billion
Growth Rate (CAGR)5.4%
Most Critical Decision FactorSecure component and isotope supply continuity
Largest RegionSouth Region (U.S. Census)
Competitive StructureConcentrated oligopoly led by GE HealthCare, Siemens Healthineers, and Philips

Leading Market Participants

  • GE HealthCare
  • Siemens Healthineers
  • Philips
  • Canon Medical Systems USA
  • Fujifilm Healthcare Americas
  • Hologic
  • Carestream Health
  • Varex Imaging
  • RadNet
  • Lantheus

Regulatory and Trade Policy Environment

USMCA governs duty-free trade in imaging equipment and components between the United States, Mexico, and Canada, with rules of origin determining tariff treatment for detector modules and cable assemblies. Imports from most other origins face low Most Favored Nation duty rates, but Section 301 duties apply to many Chinese-origin products. The FDA regulates devices through 510(k) clearance and premarket approval, creating a time-consuming gate for new modality imports.

Federal procurement rules under the Buy American Act and Trade Agreements Act shape government hospital purchasing, including Veterans Affairs facilities. CFIUS screens foreign acquisitions of imaging component makers with sensitive technology, while CMS reimbursement rates under the Medicare Physician Fee Schedule determine whether providers can absorb equipment costs. Customs classification under HTSUS Chapter 90 governs duty assessment for imaging systems.

U.S. Imaging Supply Chain Outlook to 2032

By 2032 the United States will shift from importing finished systems toward importing sub-assemblies and exporting high-value platforms. Reshoring of detector and magnet production will cut import dependence for CT and MR, while helium recycling in hospitals reduces demand for new supply. Trade flows will favor Mexico for components and Germany and Japan for premium modalities.

Technology will reshape comparative advantage. Photon-counting CT, which Siemens Healthineers and GE HealthCare are advancing, requires specialized detector materials that favor producers with tight control over semiconductor inputs. Low-field portable MRI and AI-enabled ultrasound will lower capital intensity, enabling domestic makers such as Hyperfine and Butterfly Network to capture export share in emerging markets.

Frequently Asked Questions

Finished X-ray and ultrasound systems rely heavily on imports from Germany, the Netherlands, and Japan. Domestic assembly by GE HealthCare and Siemens Healthineers covers a large share of CT and MRI volume.
Helium for MRI magnets and molybdenum-99 for nuclear imaging carry the highest exposure. Both depend on a small number of foreign or reserve-linked suppliers.
USMCA allows duty-free movement of qualifying detector modules and cable assemblies from Mexico. Rules of origin determine eligibility, so manufacturers must document regional content carefully.
Section 301 duties on Chinese-origin components raise landed costs for X-ray tubes and detectors. Pending Section 232 action on medical devices adds further uncertainty for hospital budgets.
Procurement teams should track the Section 232 outcome and helium contract pricing. Refurbished system availability and currency movements in euro and yen also affect total acquisition cost.

Market Segmentation

By Modality
  • Computed Tomography
  • Magnetic Resonance Imaging
  • X-ray Systems
  • Ultrasound
  • Nuclear Imaging
By End User
  • Hospitals
  • Outpatient Imaging Centers
  • Diagnostic Imaging Chains
  • Academic Research Institutes
  • Veterans Affairs Facilities
By Component
  • X-ray Tubes
  • Detectors
  • Superconducting Magnets
  • Contrast Agents
  • Radiopharmaceuticals

Table of Contents

Chapter 01 Methodology and Scope
1.1 Research Methodology
1.2 Scope and Definitions
1.3 Data Sources
Chapter 02 Executive Summary
2.1 Report Highlights
2.2 Market Size and Forecast 2024-2032
Chapter 03 U.S. Medical Imaging - Market Analysis
3.1 Market Overview
3.2 Growth Drivers
3.3 Restraints
3.4 Opportunities
Chapter 04 Modality Insights
4.1 Computed Tomography
4.2 Magnetic Resonance Imaging
4.3 X-ray Systems
4.4 Ultrasound
4.5 Others
Chapter 05 End User Insights
5.1 Hospitals
5.2 Outpatient Imaging Centers
5.3 Diagnostic Imaging Chains
5.4 Academic Research Institutes
5.5 Others
Chapter 06 Component Insights
6.1 X-ray Tubes
6.2 Detectors
6.3 Superconducting Magnets
6.4 Contrast Agents
6.5 Others
Chapter 07 Competitive Landscape
7.1 Market Players
7.2 Leading Market Participants
7.2.1 GE HealthCare
7.2.2 Siemens Healthineers
7.2.3 Philips
7.2.4 Canon Medical Systems USA
7.2.5 Fujifilm Healthcare Americas
7.2.6 Hologic
7.2.7 Carestream Health
7.2.8 Varex Imaging
7.2.9 RadNet
7.2.10 Lantheus
7.3 Regulatory Environment
7.4 Outlook

Research Framework and Methodological Approach

Information
Procurement

Information
Analysis

Market Formulation
& Validation

Overview of Our Research Process

MarketsNXT follows a structured, multi-stage research framework designed to ensure accuracy, reliability, and strategic relevance of every published study. Our methodology integrates globally accepted research standards with industry best practices in data collection, modeling, verification, and insight generation.

1. Data Acquisition Strategy

Robust data collection is the foundation of our analytical process. MarketsNXT employs a layered sourcing model.

Secondary Research
  • Company annual reports & SEC filings
  • Industry association publications
  • Technical journals & white papers
  • Government databases (World Bank, OECD)
  • Paid commercial databases
Primary Research
  • KOL Interviews (CEOs, Marketing Heads)
  • Surveys with industry participants
  • Distributor & supplier discussions
  • End-user feedback loops
  • Questionnaires for gap analysis

Analytical Modeling and Insight Development

After collection, datasets are processed and interpreted using multiple analytical techniques to identify baseline market values, demand patterns, growth drivers, constraints, and opportunity clusters.

2. Market Estimation Techniques

MarketsNXT applies multiple estimation pathways to strengthen forecast accuracy.

Bottom-up Approach

Country Level Market Size
Regional Market Size
Global Market Size

Aggregating granular demand data from country level to derive global figures.

Top-down Approach

Parent Market Size
Target Market Share
Segmented Market Size

Breaking down the parent industry market to identify the target serviceable market.

Supply Chain Anchored Forecasting

MarketsNXT integrates value chain intelligence into its forecasting structure to ensure commercial realism and operational alignment.

Supply-Side Evaluation

Revenue and capacity estimates are developed through company financial reviews, product portfolio mapping, benchmarking of competitive positioning, and commercialization tracking.

3. Market Engineering & Validation

Market engineering involves the triangulation of data from multiple sources to minimize errors.

01 Data Mining

Extensive gathering of raw data.

02 Analysis

Statistical regression & trend analysis.

03 Validation

Cross-verification with experts.

04 Final Output

Publication of market study.

Client-Centric Research Delivery

MarketsNXT positions research delivery as a collaborative engagement rather than a static information transfer. Analysts work with clients to clarify objectives, interpret findings, and connect insights to strategic decisions.